Skip to main content
ERAS
NASDAQ Life Sciences

Erasca Reports Q4 Net Loss of $29.1M, Basic EPS at -$0.1

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$14.74
Mkt Cap
$4.535B
52W Low
$1.01
52W High
$16.405
52W Position info
1359% above low
Off High info
10% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ERAS has more than doubled off its 52-week low of $1.01.

Summary

Erasca reported a Q4 basic EPS of -$0.1 and a net loss of $29.092 million, with operating expenses reaching $32.604 million. These financial results indicate continued losses for the clinical-stage biotechnology company. While the company has recently announced positive developments in clinical collaborations and securing rights for its pan-RAS molecular glue, ERAS-0015, these Q4 financial results highlight the ongoing cash burn typical for a company in its development phase. Traders will monitor future earnings reports for progress towards profitability and the impact of R&D investments.

At the time of this announcement, ERAS was trading at $14.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.5B. The 52-week trading range was $1.01 to $16.41. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ERAS - Latest Insights

ERAS
Nov 17, 2026, 6:40 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $13.99
Real-time Price: $14.13 info
Change: +$0.140 (+1%) info
Market Cap: $4.991B info
ERAS
Nov 12, 2026, 4:03 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $15.78
Real-time Price: $14.13 info
Change: -$1.65 (-10%) info
Market Cap: $4.991B info
ERAS
Nov 12, 2026, 4:01 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $15.78
Real-time Price: $14.13 info
Change: -$1.65 (-10%) info
Market Cap: $4.991B info
ERAS
Aug 24, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.11
Real-time Price: $14.13 info
Change: -$3.98 (-22%) info
Market Cap: $4.991B info
ERAS
Aug 24, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $18.11
Real-time Price: $14.13 info
Change: -$3.98 (-22%) info
Market Cap: $4.991B info